Michael Blaha News Today

Michael Blaha, MD, highlights the potential of GLP-1 agonists in lowering LDL cholesterol, triglycerides, and body weight in patients with diabetes, presenting them as an additional option for reducing cardiovascular risk in this patient population.

Similar to secondhand cigarette smoke, this exposure is being labelled an 'invisible threat' by scientists.

A REDUCE-IT analysis highlights consistent cardiovascular benefits with icosapent ethyl across varying levels of Lp(a).

At NYFW, models hit the runway in power suits toting a cigarette between their fingers, signaling a possible resurgence of smoking, despite years of health advisories and campaigns against big tobacco.

Universal risk predictor for cardiovascular disease, suitable for use in both primary and secondary prevention, would streamline risk assessment 

Developed by Bloomberg School researchers, the model could change how doctors worldwide assess patients' chances for heart attacks, strokes, and other cardiac events

Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single “universal risk prediction model” for cardiovascular disease th

Utility industry news and analysis for energy professionals.

Jackson Allard, 22, was found suffering from Influenza 4 and double pneumonia due to vaping. He had to have a double lung transplant to survive

2019 federal law raised minimum age to 21. Vaping, not cigarettes, are oft-flavored favorite of teens.